Rock Springs Capital Management’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.7M | Sell |
450,374
-344,063
| -43% | -$15M | 1.22% | 30 |
|
|
2025
Q1 | $21.7M | Sell |
794,437
-239,700
| -23% | -$6.56M | 1.24% | 29 |
|
|
2024
Q4 | $41.6M | Sell |
1,034,137
-15,249
| -1% | -$613K | 1.58% | 20 |
|
|
2024
Q3 | $49.7M | Sell |
1,049,386
-114,587
| -10% | -$5.42M | 1.62% | 22 |
|
|
2024
Q2 | $34.7M | Sell |
1,163,973
-358,265
| -24% | -$10.7M | 1.05% | 38 |
|
|
2024
Q1 | $61.2M | Hold |
1,522,238
| – | – | 1.55% | 21 |
|
|
2023
Q4 | $38.8M | Buy |
1,522,238
+17,887
| +1% | +$455K | 0.95% | 36 |
|
|
2023
Q3 | $20.9M | Buy |
1,504,351
+16,800
| +1% | +$234K | 0.56% | 56 |
|
|
2023
Q2 | $34.2M | Buy |
1,487,551
+259,172
| +21% | +$5.96M | 0.81% | 40 |
|
|
2023
Q1 | $36.4M | Buy |
1,228,379
+600
| +0% | +$17.8K | 0.87% | 44 |
|
|
2022
Q4 | $30.6M | Buy |
1,227,779
+181,036
| +17% | +$4.52M | 0.74% | 46 |
|
|
2022
Q3 | $22.8M | Buy |
1,046,743
+270,864
| +35% | +$5.9M | 0.59% | 50 |
|
|
2022
Q2 | $15.3M | Buy |
775,879
+20,004
| +3% | +$394K | 0.44% | 61 |
|
|
2022
Q1 | $32M | Buy |
755,875
+13,810
| +2% | +$584K | 0.81% | 42 |
|
|
2021
Q4 | $47.1M | Buy |
742,065
+9,138
| +1% | +$580K | 1.09% | 31 |
|
|
2021
Q3 | $43.1M | Buy |
732,927
+106,400
| +17% | +$6.25M | 0.91% | 38 |
|
|
2021
Q2 | $30.4M | Buy |
626,527
+4,750
| +0.8% | +$230K | 0.6% | 54 |
|
|
2021
Q1 | $24.2M | Sell |
621,777
-92,088
| -13% | -$3.58M | 0.53% | 66 |
|
|
2020
Q4 | $44.3M | Buy |
713,865
+3,900
| +0.5% | +$242K | 0.94% | 34 |
|
|
2020
Q3 | $22.9M | Buy |
+709,965
| New | +$22.9M | 0.58% | 58 |
|